2016 London Healthcare Conference
March 1 - 2, 2016
, Credit Suisse Offices
, London
| Presenter Name | Ticker | Analyst Rating | Speakers | Country | Sector | Status | USD Marketcap | Category | |
|---|---|---|---|---|---|---|---|---|---|
|
Ablynx
|
ABLX.BR |
Edwin Moses
,
CEO
Marieke Vermeersch
,
Director, Investor Relations and Corporate Communications
|
Confirmed | Participating Companies | |||||
|
Actelion Pharmaceuticals Ltd
|
ATLN.VX |
Andrew Weiss
,
SVP, IR & Corp. Communications
|
Confirmed | Participating Companies | |||||
|
Adaptimmune
|
James Noble
,
CEO
|
Confirmed | Participating Companies | ||||||
|
Alkermes
|
ALKS |
Richard Pops
,
CEO
Shane Cooke
,
President
|
Confirmed | Participating Companies | |||||
|
Almirall
|
ALM.MC |
Daniel Martinez
,
CFO
Pablo Divasson Del Fraile
,
Head of Investor Relations
|
Spain | Confirmed | Participating Companies | ||||
|
AMBU
|
AMBUB |
Lars Marcher
,
President & CEO
|
Confirmed | Participating Companies | |||||
|
Amgen Inc.
|
AMGN |
Arvind Sood
,
Vice President, Investor Relations
|
United States | Confirmed | Participating Companies | ||||
|
AstraZeneca
|
AZN.L |
Luke Miels
,
EVP, Global Product & Portfolio Management, Global Medical Affairs and Corporate Affairs.
Craig Marks
,
Director, Investor Relations
|
United Kingdom | Confirmed | Participating Companies | ||||
|
Basilea Pharmaceutica Ltd
|
BSLN.S |
Ronald Scott
,
CEO
Adesh Kaul
,
Head of Corporate Development
|
Switzerland | Confirmed | Participating Companies | ||||
|
BTG plc
|
BTG.L |
Rolf Soderstrom
,
CFO
Andy Burrows
,
VP Corporate and Investor Relations
|
Confirmed | Participating Companies | |||||
|
Cassiopea
|
Chris Tanner
,
CFO& Head of IR
|
Confirmed | Participating Companies | ||||||
|
Coloplast B
|
COLOb.CO |
Anders Lonning-Skovgaard
,
CFO
Ellen Bjurgert
,
Investor Relations Manager
|
Denmark | Confirmed | Participating Companies | ||||
|
Cosmo Pharmaceuticals
|
COPN.S |
Alessandro Della Cha
,
CEO
Chris Tanner
,
CFO & Head of IR
|
Consumer Staples | Confirmed | Participating Companies | ||||
|
Credit Suisse European Medtech Analyst
|
Christoph Gretler
,
Credit Suisse
Thomas C. Kaufmann
,
Credit Suisse
|
Switzerland | Confirmed | N/A | Participating Companies | ||||
|
Credit Suisse European Pharma Team
|
Jo Walton
Matt Weston
Phil Gestrin
|
Confirmed | Participating Companies | ||||||
|
Credit Suisse HOLT - Healthcare Specialist Analyst
|
United Kingdom | Confirmed | N/A | Participating Companies | |||||
|
Credit Suisse US Large Cap Biotech Analyst
|
Alethia Young
,
Director
|
United States | Confirmed | N/A | Participating Companies | ||||
|
Credit Suisse US Lifescience Tools, CROs & Animal Health Analyst
|
United Kingdom | Confirmed | N/A | Participating Companies | |||||
|
Credit Suisse US Major Pharma Analyst
|
Vamil Divan
,
Director
,
Credit Suisse
|
United States | Confirmed | N/A | Participating Companies | ||||
|
Credit Suisse US SMidcap Biotech Analyst
|
Kennen MacKay
,
Vice President
,
Credit Suisse
|
United States | Confirmed | N/A | Participating Companies | ||||
|
Credit Suisse US Specialist and US Trader
|
Shantha Ozgen
|
United States | Confirmed | N/A | Participating Companies | ||||
|
Fresenius
|
FREG.DE |
Florian Feick
,
Senior Manager Investor Relations
Sebastian Schlagwein
,
Senior Manager Investor Relations
|
Germany | Confirmed | Participating Companies | ||||
|
Fresenius Medical Care AG & Co. KGaA
|
FMEG:DE, FMEG:DE | N/A |
Oliver Maier
,
SVP & Head of Investor Relations & Corporate Communications
,
Fresenius Medical Care
(FMEG:DE)
Robert Adolph
,
Director of Investor Relations
,
Fresenius Medical Care
(FMEG:DE)
|
Confirmed | N/A | Participating Companies | |||
|
Galapagos
|
GLPG.BR |
Onno Van de Stolpe
,
CEO
|
Confirmed | Participating Companies | |||||
|
Genmab
|
GEN.CO |
Jan van de Winkel
,
President & CEO
David Eatwell
,
Executive Vice President and Chief Financial Officer
Rachel Curtis Gravesen
,
Senior Vice President, IR & Communications
|
Denmark | Confirmed | Participating Companies | ||||
|
Gerresheimer AG
|
GXIG.DE |
Rainer Beaujean
,
CFO
Benjamin Strohmeyer
,
Manager Corporate Investor Relations & Creditor Relations
|
Germany | Confirmed | Participating Companies | ||||
|
GlaxoSmithKline
|
GSK.L |
Simon Dingemans
,
CFO
Ziba Shamsi
,
Global Head of IR
|
United Kingdom | Health Care | Confirmed | Participating Companies | |||
|
GN Store Nord
|
GN.CO |
Michael Nass Nielsen
,
IR Manager
|
Denmark | Confirmed | Participating Companies | ||||
|
Haemophilia Expert, Imperial College London
|
Michael Laffan
,
Professor of Haemostasis and Thrombosis
|
Confirmed | Participating Companies | ||||||
|
Hypermarcas
|
HYPE3 |
Breno Oliveira
,
IR & Treasury Director
Renato Braun
,
Senior IR Manager
|
Brazil | Confirmed | Participating Companies | ||||
|
IMS Institute for Payer & Managed Care Insights
|
Mason Tenaglia
,
Vice President
|
Confirmed | Participating Companies | ||||||
|
Incyte
|
Herve Hoppenot
,
Chairman, President and CEO
|
Confirmed | Participating Companies | ||||||
|
Indivior
|
INDV.L |
Tom Corran
,
IR
|
Confirmed | Participating Companies | |||||
|
Innate Pharma
|
IPH.PA |
Pierre Dodion
,
CMO
Nicolai Wagtmann
,
CSO
|
Confirmed | Participating Companies | |||||
|
Ipsen
|
IPN.PA |
Marc de Garidel
,
CEO
Aymeric Le Chatelier
,
Group CFO
Stéphane Durant des Aulnois
,
Head of Investor Relations
|
France | Confirmed | Participating Companies | ||||
|
Kite Pharma, Inc.
|
KITE |
Cynthia Butitta
,
COO/CFO
David Chang
,
EVP, R&D, and CMO
Kate Bechtold
,
IR
|
Confirmed | Participating Companies | |||||
|
Lundbeck
|
LUN.CO |
Anders Goetzsche
,
Executive Vice President & CFO
Palle Olesen
,
Vice President, Investor Relations
|
Confirmed | Participating Companies | |||||
|
MacroGenics
|
MGNX |
Scott Koenig
,
President & CEO
James Karrels
,
CFO
|
Confirmed | Participating Companies | |||||
|
Medivation, Inc.
|
MDVN |
David Hung
,
Founder, President and CEO
Dominic Piscitelli
,
VP, Finance
|
Confirmed | Participating Companies | |||||
|
Merck & Co.
|
MRK |
Amy Klug
,
Director, Investor Relations
Teri Loxam
,
VP, IR
|
United States | Confirmed | Participating Companies | ||||
|
Merrimack Pharmaceuticals, Inc.
|
MACK |
Yasir Al-Wakeel
,
CFO & Head of Corporate Development
Geoffrey Grande
,
Investor Relations
|
Confirmed | Participating Companies | |||||
|
Molecular Partners
|
Christian Zahnd
,
CEO
Andreas Emmenegger
,
CFO
|
Confirmed | Participating Companies | ||||||
|
Novartis
|
NOVN.VX |
Harry Kirsch
,
CFO
Isabella Zinck
,
Investor Relations
|
Switzerland | Confirmed | Participating Companies | ||||
|
Novo Nordisk
|
NOVOb.CO |
Melanie Raouzeos
,
IR Manager
Hanna Ögren
,
Investor Relations Manager
|
Denmark | Confirmed | Participating Companies | ||||
|
Orion
|
ORNBV.HE |
Paula Rytilä
,
Medical Director
Tuukka Hirvonen
,
IR
|
Finland | Confirmed | Participating Companies | ||||
|
ProBiodrug
|
Hendrik Liebers
,
CFO
Supriya Mathur
,
Director International Healthcare
Eva Haas
,
Senior Consultant
|
Confirmed | Participating Companies | ||||||
|
Recordati
|
RECI.MI |
Marianne Tatschke
,
Director of Investor Relations & Corporate Comunications
Fritz Squindo
,
CFO and General Manager
|
Italy | Confirmed | Participating Companies | ||||
|
Regeneron Pharmaceutical
|
REGN |
Robert Landry
,
CFO
Manisha Narasimhan
,
Assoc. Director, Investor Relations
|
United States | Participating Companies | |||||
|
Roche
|
ROG |
Sabine Borngräber
,
Investor Relations Officer
Bruno Eschli
,
Investor Relations Office
|
Confirmed | Participating Companies | |||||
|
ROVI
|
ROVI.O |
Javier López-Belmonte
,
Chief Financial Officer
Marta Campos
,
Investor Relations
|
Confirmed | Participating Companies | |||||
|
Sanofi
|
SASY.PA |
Jerome Contamine
,
CFO
Sebastien Martel
,
VP - Head of Investor Relations
Philippe Zeisser
,
AVP Investor Relations
|
France | Confirmed | Participating Companies | ||||
|
Sartorius AG
|
SATG.DE |
Andreas Theisen
,
Director Investor Relations
Svenja Schildknecht
,
Manager Investor Relations
|
Confirmed | Participating Companies | |||||
|
Shire Pharmaceuticals
|
SHPG |
Sarah Elton-Farr
,
Senior Director, IR
|
United Kingdom | Confirmed | Participating Companies | ||||
|
Sonova
|
SOON.VX |
Lukas Braunschweiler
,
CEO
|
Switzerland | Confirmed | Participating Companies | ||||
|
Teva Pharmaceutical Industries
|
TEVA |
Rob Koremans, MD
,
President and CEO of Teva Global Specialty Medicines
Heike Hartwig
,
Chief of Staff, CEO Global Specialty Medicines
Ran Meir
,
VP, Investor Relations
Mary Clark
,
Consultant
|
Israel | Confirmed | Participating Companies | ||||
|
TxCell
|
TXCL |
Stephane Boissel
,
CEO
|
Confirmed | Participating Companies | |||||
|
UCB
|
UCB.BR |
Jean - Christophe Tellier
,
CEO
Detlef Thielgen
,
CFO
Iris Löw-Friedrich
,
CMO
Antje Witte
,
VP Investor Relations
Isabelle Ghellynck
,
Associate Director Investor Relations
|
Belgium | Confirmed | Participating Companies | ||||
|
UDG Healthcare
|
UDG.L |
Keith Byrne
,
Head of Investor Relations and Strategy
|
Confirmed | Participating Companies | |||||
|
Valneva
|
VLA |
Thomas Lingelbach
,
President and CEO
Reinhard Kandera
,
CFO
|
Confirmed | Participating Companies | |||||
|
Vertex Pharmaceuticals
|
VRTX |
Eric Rojas
,
Senior Director Investor Relations
Simon Bedson
,
SVP and General Manager International Commercial
|
United States | Confirmed | Participating Companies | ||||
|
Zealand Pharma
|
ZELA.CO |
Mats Blom
,
CFO
|
Confirmed | Participating Companies | |||||
|
Zoetis
|
Clint Lewis
,
Executive Vice President and President, International Operations
John O'Connor
,
Vice President, Investor Relations
|
Confirmed | Participating Companies |
